A randomised joint Australasian (ALLG) and French (FILO) study of lenalidomide consolidation in patients with residual CLL after front-line treatment with FC/FCR (the CLL6 Trial)
D. Gottlieb, T Aurran-Schleinitz, S. Mulligan, R. Letestu, M. Sartor, M. Bene, B. Kuss, R. Delepine, U. Nguyen, B. Butcher, F. Dreyfus, C. Tam, F. Cymbalista
Research output: Contribution to journal › Meeting Abstract › peer-review
Fingerprint
Dive into the research topics of 'A randomised joint Australasian (ALLG) and French (FILO) study of lenalidomide consolidation in patients with residual CLL after front-line treatment with FC/FCR (the CLL6 Trial)'. Together they form a unique fingerprint.